Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 0.10%-257.44K | -6.28%-287.32K | -90.98%-243.92K | -12.98%-996.22K | -33.69%-340.47K | -39.07%-257.69K | -221.55%-270.34K | 64.30%-127.72K | 51.65%-881.76K | -487.16%-254.66K |
| Net income from continuing operations | -2.94%-340.7K | 13.98%-216.06K | -17.71%-260.22K | 39.39%-1.36M | 52.96%-559.78K | -18.78%-330.97K | 1.15%-251.19K | 57.99%-221.07K | 43.66%-2.25M | -96.02%-1.19M |
| Operating gains losses | ---19.88K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | -33.92%62.99K | ---- | ---- | -47.13%374.7K | -60.58%279.38K | --95.33K | ---- | ---- | 41,664.35%708.74K | --708.74K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --244.34K | ---- |
| Other non cashItems | ---- | ---- | ---- | ---10.6K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 282.11%40.15K | -271.91%-71.25K | -82.54%16.3K | -99.35%2.68K | -178.40%-49.46K | -123.62%-22.05K | -111.27%-19.16K | -44.61%93.35K | 292.81%414.13K | -101.89%-17.77K |
| -Change in receivables | 248.70%10.89K | -335.66%-28.95K | -62.07%23.04K | -36.51%41.19K | -1,640.41%-24.51K | -107.68%-7.32K | 149.23%12.28K | 1,612.68%60.73K | 145.98%64.88K | -196.50%-1.41K |
| -Change in prepaid assets | --0 | -100.04%-2 | --0 | -95.19%13.16K | 106.59%1.45K | -87.60%4.11K | -95.93%5K | -98.14%2.6K | 171.51%273.82K | -110.94%-22.04K |
| -Change in payables and accrued expense | 255.35%29.26K | -16.07%-42.3K | -122.44%-6.74K | -168.50%-51.67K | -565.01%-26.41K | 46.25%-18.84K | -150.49%-36.44K | -8.00%30.02K | 110.07%75.43K | 101.77%5.68K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 0.10%-257.44K | -6.28%-287.32K | -90.98%-243.92K | -12.98%-996.22K | -33.69%-340.47K | -39.07%-257.69K | -221.55%-270.34K | 64.30%-127.72K | 51.65%-881.76K | -487.16%-254.66K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -552.25%-57.33K | 67.39%-25K | 41.94%-87.62K | 100.60%407 | 57.22%-2.57K | 88.34%-8.79K | -4,341.95%-76.67K | -1,128.19%-150.92K | -159.45%-67.83K |
| Net PPE purchase and sale | --0 | -552.25%-57.33K | 67.39%-25K | 41.94%-87.62K | 100.60%407 | 57.22%-2.57K | 88.34%-8.79K | -4,341.95%-76.67K | -234.53%-150.92K | -183.47%-67.83K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -552.25%-57.33K | 67.39%-25K | 41.94%-87.62K | 100.60%407 | 57.22%-2.57K | 88.34%-8.79K | -4,341.95%-76.67K | -1,128.19%-150.92K | -159.45%-67.83K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 422.97%146.83K | -122.48%-11.77K | 128.02%80.96K | 121.40%150.73K | 179.94%34.81K | -40.88%28.08K | 3,681.86%52.34K | 423.97%35.5K | -98.79%68.08K | 101.86%12.44K |
| Net common stock issuance | --75K | ---- | ---- | --40K | --40K | --0 | ---- | ---- | --0 | ---- |
| Net other financing activities | 155.83%71.83K | -122.48%-11.77K | 128.02%80.96K | 62.64%110.73K | -141.74%-5.19K | -40.88%28.08K | 3,681.86%52.34K | 423.97%35.5K | 780.82%68.08K | 105.80%12.44K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 422.97%146.83K | -122.48%-11.77K | 128.02%80.96K | 121.40%150.73K | 179.94%34.81K | -40.88%28.08K | 3,681.86%52.34K | 423.97%35.5K | -98.79%68.08K | 101.86%12.44K |
| Net cash flow | ||||||||||
| Beginning cash position | -44.03%1.38M | -35.48%1.73M | -32.71%1.92M | -25.27%2.85M | -29.65%2.23M | -25.69%2.46M | -22.54%2.68M | -25.27%2.85M | 13,240.43%3.82M | -28.35%3.16M |
| Current changes in cash | 52.37%-110.58K | -57.15%-356.41K | -11.30%-187.97K | 3.26%-933.11K | 1.55%-305.25K | -61.44%-232.18K | -40.82%-226.79K | 52.11%-168.88K | -125.46%-964.6K | 48.04%-310.06K |
| End cash Position | -43.15%1.26M | -44.03%1.38M | -35.48%1.73M | -32.71%1.92M | -32.71%1.92M | -29.65%2.23M | -25.62%2.46M | -22.54%2.68M | -25.27%2.85M | -25.27%2.85M |
| Free cash from | 1.08%-257.44K | -23.47%-344.65K | -31.57%-268.92K | -4.95%-1.08M | -5.45%-340.06K | -36.05%-260.26K | -75.07%-279.13K | 43.14%-204.39K | 44.74%-1.03M | -951.08%-322.49K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.